IRMD
Iradimed Co
86.50$
+4.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.7% | +0.8% | +1.9% | +2.2% | +5.8% | +0.6% | +4.6% | +3.9% | +7.0% | -3.1% | -6.9% | – | |
| – | +10.1% | +4.2% | -6.9% | +5.5% | +12.0% | +0.9% | -4.6% | +5.7% | +20.2% | -8.7% | +2.7% | – | |
| – | +4.5% | -0.2% | +4.6% | +1.3% | +4.0% | +0.6% | +7.5% | +3.4% | +3.3% | -1.3% | -9.8% | – | |
| – | +43.7% | +26.2% | -2.4% | -20.2% | -10.9% | +9.5% | +40.5% | -23.1% | +18.5% | +19.6% | -31.3% | – | |
| – | +18.2% | -6.6% | +2.9% | -3.3% | -2.4% | +19.0% | -7.2% | +1.8% | +4.1% | +0.7% | -15.4% | – | |
| – | +19.1% | +4.7% | -3.0% | +0.2% | +6.6% | +5.0% | -2.6% | +5.4% | +2.9% | -3.6% | -8.4% | – | |
| – | -12.6% | -8.0% | +18.5% | +2.9% | +0.2% | -6.4% | +25.0% | +0.7% | +3.8% | +2.0% | -11.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.3% | -7.7% | +19.6% | +2.4% | -1.2% | -6.3% | +23.2% | -0.4% | +6.8% | -0.3% | -11.3% | – | |
| – | -14.9% | -3.1% | +23.6% | +0.1% | -12.5% | +5.0% | +23.5% | +10.8% | -21.6% | +44.6% | -14.4% | – | |
| – | -10.4% | -8.9% | +18.5% | +3.0% | +1.9% | -8.9% | +23.2% | -3.4% | +15.5% | -9.7% | -10.3% | – | |
| – | -10.8% | -7.1% | +18.3% | +2.3% | -1.2% | -6.1% | +29.0% | -3.0% | +9.4% | -2.2% | -17.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.